Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MIST is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
20 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 10
78 filers reported a long position in MIST for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Pavaki Capital Management LLC | $12.2M | 9.1M | +0.1% |
| RTW INVESTMENTS, LP | $10.5M | 7.8M | +23.7% |
| Propel Bio Management, LLC | $10M | 7.4M | +80.4% |
| Point72 Asset Management, L.P. | $7.3M | 5.4M | +398.4% |
| Simplify Asset Management Inc. | $4.5M | 3.3M | +122.3% |
| MILLENNIUM MANAGEMENT LLC | $4.2M | 3.1M | +103.5% |
| TWO SIGMA INVESTMENTS, LP | $2.7M | 2M | -12% |
| MARSHALL WACE, LLP | $2.4M | 1.8M | -7.6% |
| Kalehua Capital Management LLC | $1.7M | 1.3M | New |
| Lion Point Capital, LP | $1.1M | 820K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.